Scotia Capital’s Amyris Inc. AMRS Stock Holding History

Scotia Capital’s Portfolio AMRS Stock Details AMRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-19,882	Closed	-$273K	–	923
2021 Q3	$273K	Buy	+19,882	New	+$285K	﹤0.01%	744

Other funds holding AMRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Scotia Capital's AMRS Position: Q4 2021 in Review

Scotia Capital sold out of Amyris Inc. (AMRS) in Q4 2021, closing a stake of 19,882 shares — an estimated $273K sold.

Scotia Capital first reported a position in AMRS in Q3 2021 and held it in 1 quarter. The position peaked at $273K in Q3 2021. 237 funds tracked by Wall St. Rank hold AMRS as of Q4 2021.

Scotia Capital reported no remaining Amyris Inc. position as of Q4 2021 after selling out during the quarter.
Scotia Capital sold 19,882 Amyris Inc. shares in Q4 2021, an estimated $273K.
Scotia Capital first reported a position in Amyris Inc. in Q3 2021 and held it in 1 quarter.
Scotia Capital's Amyris Inc. position peaked at $273K in Q3 2021.
237 funds tracked by Wall St. Rank held Amyris Inc. as of Q4 2021.

Based on Scotia Capital's 13F filing for Q4 2021, filed 11 Feb 2022.